Apeloa Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company with a risk rating score of 41.5, indicating severe risk. This company specializes in the research, development, manufacturing, and marketing of APIs formulations and veterinary drugs, offering products such as Ofloxacin, Levofloxacin Hydrochloride, and Marbofloxacin. Invest in pharmaceuticals with a focus on ESG for sustainability and governance.